Home > Financial Ratios > WINDLAS BIOTECH

WINDLAS BIOTECH
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Working Capital/Sales(x) 2.962.752.432.211.62

What is the latest Working Capital/Sales ratio of WINDLAS BIOTECH ?

The latest Working Capital/Sales ratio of WINDLAS BIOTECH is 2.96 based on Mar2026 Consolidated results.
Year Working Capital/Sales
Mar20262.96
Mar20252.75
Mar20242.43
Mar20232.21
Mar20221.62

How is Working Capital/Sales of WINDLAS BIOTECH Trending?

Years Working Capital/Sales % Change
Mar2026 2.96
7.64
Mar2025 2.75
13.17
Mar2024 2.43
9.95
Mar2023 2.21
36.42
Mar2022 1.62 -

Other Financial Ratios of WINDLAS BIOTECH


Compare Working Capital/Sales ratio of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,762.1 Cr -0.5% -0.3% -7.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹477,408.0 Cr 1.8% 6.8% 17.8% Stock Analytics
DIVIS LABORATORIES ₹206,906.0 Cr 6.7% 18.5% 12.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,521.0 Cr -3.7% 5.5% 39.8% Stock Analytics
CIPLA ₹119,032.0 Cr 5.7% 0.6% -1.4% Stock Analytics
DR REDDYS LABORATORIES ₹95,420.1 Cr -2% -15.8% -8.4% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-0.5%

-0.3%

-7.2%

SENSEX

1.2%

1.2%

-5.5%


You may also like the below Video Courses